Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-20 5:17 pm Sale | 2025-08-18 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 3,735,220 7.600% | -2,491,172 (-40.01%) | Filing History |
| 2024-11-06 10:26 am Purchase | 2024-09-30 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Frazier Life Sciences IX, L.P. | 1,587,527 4.200% | 170,370 (+12.02%) | Filing History |
| 2023-09-05 3:11 pm Purchase | 2023-08-31 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 6,226,392 13.400% | 1,815,285 (+41.15%) | Filing History |
| 2023-06-15 10:25 am Sale | 2023-06-13 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX, L.P. | 127,185 4.700% | -60,661 (-32.29%) | Filing History |
| 2023-04-14 12:45 pm Purchase | 2023-04-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 4,411,107 11.600% | 549,326 (+14.22%) | Filing History |
| 2022-09-26 4:00 pm Purchase | 2022-09-22 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences IX, L.P. | 8,424,772 21.500% | 203,448 (+2.47%) | Filing History |
| 2022-08-16 12:20 pm Purchase | 2022-08-12 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 3,861,781 10.500% | 294,869 (+8.27%) | Filing History |
| 2022-08-15 11:29 am Sale | 2022-08-11 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX, L.P. | 187,846 6.900% | -63,226 (-25.18%) | Filing History |
| 2022-08-11 3:55 pm Purchase | 2022-08-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences IX, L.P. | 8,221,324 21.000% | 2,377,400 (+40.68%) | Filing History |
| 2022-01-28 2:09 pm Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Frazier Life Sciences IX, L.P. | 1,417,157 6.900% | -500,000 (-26.08%) | Filing History |
| 2021-02-04 4:35 pm Unchanged | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | Frazier Life Sciences IX, L.P. | 895,000 4.500% | 0 (Unchanged) | Filing History |
| 2021-01-27 2:56 pm Purchase | 2021-01-26 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX, L.P. | 251,072 9.500% | 611 (+0.24%) | Filing History |
| 2020-12-23 1:08 pm Unchanged | 2020-12-21 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences IX, L.P. | 5,843,924 18.700% | 0 (Unchanged) | Filing History |
| 2020-12-18 12:40 pm Unchanged | 2020-12-17 | 13D | Mirum Pharmaceuticals, Inc. MIRM | Frazier Life Sciences IX, L.P. | 3,566,912 12.200% | 0 (Unchanged) | Filing History |
| 2020-10-23 1:40 pm Purchase | 2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Frazier Life Sciences IX, L.P. | 1,917,157 9.500% | 1,917,157 (New Position) | Filing History |